A Needs-Based Rheumatologist Education Program on Treating to Target in Psoriatic Arthritis and Spondyloarthropathy: Insights and Challenges
| Autor: | Gina Rohekar, Paul C Tingey, Sherry Rohekar, Angela Montgomery, Pauline Boulos, Maggie Larché, Linda Wang, Vandana Ahluwalia, Janet E. Pope, Sara Haig, Nikhil Chopra, Art Karasik |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
musculoskeletal diseases
030203 arthritis & rheumatology 0301 basic medicine Ankylosing spondylitis medicine.medical_specialty business.industry Spondyloarthropathy Audit Disease medicine.disease 03 medical and health sciences Psoriatic arthritis 030104 developmental biology 0302 clinical medicine Chart Needs assessment Physical therapy Medicine skin and connective tissue diseases business BASDAI |
| Zdroj: | Open Journal of Rheumatology and Autoimmune Diseases. :53-64 |
| ISSN: | 2164-005X 2163-9914 |
| DOI: | 10.4236/ojra.2017.71005 |
| Popis: | Objectives: To determine if comparative practice data and education for rheumatologists would change physician behavior for monitoring and treating psoriatic arthritis (PsA) and spondyloarthritis (SpA). Methods: Participating rheumatologists each performed a chart audit on 20 patients with PsA and SpA. Accredited education (determined by a survey and chart audits) and results of chart audits (comparing to other rheumatologists) were provided for each participant (intervention). Eight months later, a repeat chart audit by each participant was conducted on another 20 PsA and SpA patients. Changes in measurements collected, treatment given and patient characteristics pre and post intervention were analyzed. Results: Nine rheumatologists received the intervention. At baseline, most routinely monitored PsA and SpA for clinical and laboratory markers. In PsA, there was no change post-intervention in performing SJC (96%), TJC (≥91%), ESR (≥70%), CRP (≥73%), and CDAI (25%). In SpA, there were increased measurements of inflammatory markers (54% pre vs. 61% post for CRP), more NSAID use and decreased physical exam measures and HAQ but no significant changes. There were no major treatment differences pre and post intervention including NSAIDs, DMARDs and biologics. Conclusions: The rheumatologists frequently performed measurements of disease activity, did not change significantly with educational intervention so there may have been little room for improvement and many patients were already in a low disease state. Calculation of composite scores did not increase in PsA. The validity of physical exam and BASDAI as a measurement of disease activity were noted as concerns in applying a treat-to-target approach in SpA. Significance and Innovation: This study did not show a significant change in behavior for rheumatologists who had education based on care gaps and needs assessment in psoriatic arthritis and spondyloarthropathy. The rheumatologists identified that disease activity is difficult to determine with usual care in SpA and thought some measures lacked validity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|